Atossa Net Debt vs Capital Surpluse Analysis

ATOS Stock

USD 1.66 0.14 9.21%

Atossa Genetics financial indicator trend analysis is way more than just evaluating Atossa Genetics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Atossa Genetics is a good investment. Please check the relationship between Atossa Genetics Net Debt and its Capital Surpluse accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

Net Debt vs Capital Surpluse

Net Debt vs Capital Surpluse Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Atossa Genetics Net Debt account and Capital Surpluse. At this time, the significance of the direction appears to have pay attention.

The correlation between Atossa Genetics' Net Debt and Capital Surpluse is -0.92. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Capital Surpluse in the same time period over historical financial statements of Atossa Genetics, assuming nothing else is changed. The correlation between historical values of Atossa Genetics' Net Debt and Capital Surpluse is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Atossa Genetics are associated (or correlated) with its Capital Surpluse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Surpluse has no effect on the direction of Net Debt i.e., Atossa Genetics' Net Debt and Capital Surpluse go up and down completely randomly.

Correlation Coefficient

-0.92

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Capital Surpluse

Most indicators from Atossa Genetics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Atossa Genetics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.At this time, Atossa Genetics' Sales General And Administrative To Revenue is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 27 M in 2024, whereas Selling General Administrative is likely to drop slightly above 13.3 K in 2024.

	2023	2024 (projected)
Interest Income	3.8M	4.0M
Non Recurring	415.5K	394.8K

Interest Income Non Recurring

Atossa Genetics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant And Equipment Net	Accounts Payable	Net Receivables	Short Term Investments	Inventory	Other Current Assets
Total Assets		-0.29	0.24	0.34	1.0	-1.0	-0.84	1.0	0.33	0.55	0.58	1.0	0.95	0.96	0.62	0.94	0.34	1.0	-0.37	0.96	-0.47	0.78	0.45	-0.31	0.59	0.79
Short Long Term Debt Total	-0.29		-0.21	-0.2	-0.28	0.28	0.42	-0.28	-0.31	-0.19	-0.23	-0.28	-0.28	-0.25	-0.03	-0.38	-0.2	-0.28	0.45	-0.27	0.05	-0.29	-0.31	0.77	0.01	-0.26
Other Current Liab	0.24	-0.21		0.98	0.17	-0.24	-0.4	0.24	-0.08	0.13	0.04	0.24	0.38	0.15	0.1	0.31	0.98	0.25	-0.26	0.29	-0.32	0.43	0.21	-0.19	0.27	0.23
Total Current Liabilities	0.34	-0.2	0.98		0.27	-0.34	-0.46	0.34	-0.03	0.13	0.11	0.34	0.45	0.22	0.14	0.39	1.0	0.34	-0.29	0.36	-0.26	0.57	0.31	-0.23	0.4	0.27
Total Stockholder Equity	1.0	-0.28	0.17	0.27		-1.0	-0.83	1.0	0.34	0.54	0.58	1.0	0.94	0.96	0.62	0.93	0.27	1.0	-0.36	0.95	-0.47	0.76	0.44	-0.3	0.58	0.78
Net Debt	-1.0	0.28	-0.24	-0.34	-1.0		0.83	-1.0	-0.28	-0.51	-0.54	-1.0	-0.94	-0.95	-0.58	-0.94	-0.34	-1.0	0.39	-0.94	0.48	-0.79	-0.48	0.3	-0.61	-0.76
Retained Earnings	-0.84	0.42	-0.4	-0.46	-0.83	0.83		-0.84	-0.26	-0.72	-0.7	-0.84	-0.91	-0.87	-0.72	-0.97	-0.46	-0.84	0.61	-0.9	0.56	-0.66	-0.35	0.48	-0.35	-0.83
Cash	1.0	-0.28	0.24	0.34	1.0	-1.0	-0.84		0.29	0.53	0.56	1.0	0.95	0.95	0.6	0.94	0.34	1.0	-0.39	0.95	-0.49	0.78	0.46	-0.3	0.59	0.78
Non Current Assets Total	0.33	-0.31	-0.08	-0.03	0.34	-0.28	-0.26	0.29		0.52	0.64	0.29	0.36	0.43	0.57	0.31	-0.03	0.29	0.3	0.39	0.2	0.24	-0.29	-0.4	-0.05	0.61
Non Currrent Assets Other	0.55	-0.19	0.13	0.13	0.54	-0.51	-0.72	0.53	0.52		0.9	0.53	0.73	0.73	0.88	0.69	0.13	0.53	-0.28	0.75	-0.27	0.18	-0.35	-0.22	-0.19	0.91
Other Assets	0.58	-0.23	0.04	0.11	0.58	-0.54	-0.7	0.56	0.64	0.9		0.56	0.7	0.74	0.89	0.69	0.11	0.56	-0.35	0.72	-0.14	0.41	-0.22	-0.3	0.03	0.86
Cash And Short Term Investments	1.0	-0.28	0.24	0.34	1.0	-1.0	-0.84	1.0	0.29	0.53	0.56		0.95	0.95	0.6	0.94	0.34	1.0	-0.39	0.95	-0.49	0.78	0.46	-0.3	0.59	0.78
Common Stock Total Equity	0.95	-0.28	0.38	0.45	0.94	-0.94	-0.91	0.95	0.36	0.73	0.7	0.95		0.97	0.75	0.96	0.45	0.95	-0.4	0.99	-0.53	0.7	0.26	-0.29	0.44	0.9
Common Stock Shares Outstanding	0.96	-0.25	0.15	0.22	0.96	-0.95	-0.87	0.95	0.43	0.73	0.74	0.95	0.97		0.79	0.95	0.22	0.95	-0.36	0.99	-0.49	0.67	0.23	-0.26	0.43	0.9
Non Current Liabilities Total	0.62	-0.03	0.1	0.14	0.62	-0.58	-0.72	0.6	0.57	0.88	0.89	0.6	0.75	0.79		0.71	0.14	0.6	-0.23	0.78	-0.4	0.41	-0.27	-0.06	0.13	0.9
Other Stockholder Equity	0.94	-0.38	0.31	0.39	0.93	-0.94	-0.97	0.94	0.31	0.69	0.69	0.94	0.96	0.95	0.71		0.39	0.94	-0.53	0.96	-0.54	0.72	0.39	-0.43	0.45	0.85
Total Liab	0.34	-0.2	0.98	1.0	0.27	-0.34	-0.46	0.34	-0.03	0.13	0.11	0.34	0.45	0.22	0.14	0.39		0.34	-0.29	0.36	-0.26	0.57	0.31	-0.23	0.4	0.27
Total Current Assets	1.0	-0.28	0.25	0.34	1.0	-1.0	-0.84	1.0	0.29	0.53	0.56	1.0	0.95	0.95	0.6	0.94	0.34		-0.39	0.95	-0.49	0.78	0.47	-0.3	0.6	0.78
Short Term Debt	-0.37	0.45	-0.26	-0.29	-0.36	0.39	0.61	-0.39	0.3	-0.28	-0.35	-0.39	-0.4	-0.36	-0.23	-0.53	-0.29	-0.39		-0.39	0.29	-0.47	-0.38	0.26	-0.24	-0.24
Common Stock	0.96	-0.27	0.29	0.36	0.95	-0.94	-0.9	0.95	0.39	0.75	0.72	0.95	0.99	0.99	0.78	0.96	0.36	0.95	-0.39		-0.52	0.67	0.23	-0.28	0.42	0.92
Property Plant And Equipment Net	-0.47	0.05	-0.32	-0.26	-0.47	0.48	0.56	-0.49	0.2	-0.27	-0.14	-0.49	-0.53	-0.49	-0.4	-0.54	-0.26	-0.49	0.29	-0.52		-0.32	-0.24	-0.04	-0.39	-0.38
Accounts Payable	0.78	-0.29	0.43	0.57	0.76	-0.79	-0.66	0.78	0.24	0.18	0.41	0.78	0.7	0.67	0.41	0.72	0.57	0.78	-0.47	0.67	-0.32		0.61	-0.29	0.83	0.47
Net Receivables	0.45	-0.31	0.21	0.31	0.44	-0.48	-0.35	0.46	-0.29	-0.35	-0.22	0.46	0.26	0.23	-0.27	0.39	0.31	0.47	-0.38	0.23	-0.24	0.61		-0.4	0.71	-0.09
Short Term Investments	-0.31	0.77	-0.19	-0.23	-0.3	0.3	0.48	-0.3	-0.4	-0.22	-0.3	-0.3	-0.29	-0.26	-0.06	-0.43	-0.23	-0.3	0.26	-0.28	-0.04	-0.29	-0.4		0.06	-0.29
Inventory	0.59	0.01	0.27	0.4	0.58	-0.61	-0.35	0.59	-0.05	-0.19	0.03	0.59	0.44	0.43	0.13	0.45	0.4	0.6	-0.24	0.42	-0.39	0.83	0.71	0.06		0.15
Other Current Assets	0.79	-0.26	0.23	0.27	0.78	-0.76	-0.83	0.78	0.61	0.91	0.86	0.78	0.9	0.9	0.9	0.85	0.27	0.78	-0.24	0.92	-0.38	0.47	-0.09	-0.29	0.15

Click cells to compare fundamentals

Atossa Genetics Account Relationship Matchups

Atossa Genetics fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.5M	42.8M	141.3M	123.5M	96.3M	101.1M
Other Current Liab	12.9K	13.0M	1.4M	2.6M	4.4M	2.4M
Total Current Liabilities	1.3M	15.7M	3.1M	5.6M	5.2M	3.6M
Total Stockholder Equity	13.2M	27.2M	138.1M	118.0M	91.0M	95.6M
Net Debt	(12.5M)	(39.5M)	(136.4M)	(110.9M)	(88.6M)	(84.1M)
Retained Earnings	(94.1M)	(111.9M)	(129.2M)	(156.2M)	(186.3M)	(177.0M)
Cash	12.6M	39.6M	136.4M	110.9M	88.6M	93.0M
Non Current Assets Total	170.2K	69.3K	22K	5.3M	4.0M	4.2M
Other Assets	350.0	0.0	2K	635K	730.3K	766.8K
Cash And Short Term Investments	12.6M	39.6M	136.4M	110.9M	88.6M	93.0M
Common Stock Total Equity	1.1M	1.6M	13.0M	22.8M	26.2M	27.5M
Common Stock Shares Outstanding	8.5M	11.3M	117.0M	126.6M	126.1M	132.4M
Liabilities And Stockholders Equity	14.5M	42.8M	141.3M	123.5M	96.3M	101.1M
Non Current Liabilities Total	11.1K	3.8K	1K	3.0M	3.4M	3.6M
Other Stockholder Equity	105.6M	130.5M	244.6M	250.8M	254.5M	267.2M
Total Liab	1.3M	15.7M	3.1M	5.6M	5.2M	3.6M
Total Current Assets	14.3M	42.8M	141.2M	118.2M	92.2M	96.8M
Common Stock	1.1M	1.6M	8.6M	22.8M	26.2M	27.5M
Property Plant And Equipment Net	54.5K	84.5K	38.7K	20K	18K	17.1K
Accounts Payable	293.2K	1.6M	1.7M	3.0M	806K	834.6K
Net Receivables	739.7K	634.9K	1.1M	743K	(1.5K)	(1.4K)
Inventory	972.3K	1.9M	2.6M	4.1M	1.5K	1.4K
Other Current Assets	26.1K	657.7K	1.2M	2.4M	3.6M	3.8M
Property Plant And Equipment Gross	54.5K	84.5K	20.6K	36K	32.4K	30.8K
Intangible Assets	75.7K	99.4K	68.5K	13.4K	12.0K	11.4K
Property Plant Equipment	54.5K	34.4K	38.7K	20K	18K	17.1K
Net Tangible Assets	13.2M	26.5M	137.6M	118.0M	135.7M	142.4M
Retained Earnings Total Equity	(94.1M)	(111.9M)	(129.2M)	(156.2M)	(140.6M)	(133.5M)
Capital Surpluse	105.6M	130.5M	244.6M	251.4M	289.1M	303.5M
Net Invested Capital	13.2M	27.2M	138.1M	118.0M	135.7M	142.4M
Net Working Capital	13.0M	27.1M	138.1M	112.6M	129.5M	136.0M

Pair Trading with Atossa Genetics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atossa Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atossa Genetics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Atossa Stock

0.64	EW	Edwards Lifesciences Corp Earnings Call This Week	Pair Corr
0.8	DXCM	DexCom Inc	Pair Corr

Moving against Atossa Stock

0.8	OM	Outset MedicalInc	Pair Corr
0.73	PEN	Penumbra Earnings Call This Week	Pair Corr
0.68	INNV	InnovAge Holding Corp Earnings Call This Week	Pair Corr
0.64	INMD	InMode Financial Report 7th of May 2024	Pair Corr
0.64	NARI	Inari MedicalInc	Pair Corr

The ability to find closely correlated positions to Atossa Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atossa Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atossa Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atossa Genetics to buy it.

The correlation of Atossa Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atossa Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atossa Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Atossa Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Atossa Genetics is a strong investment it is important to analyze Atossa Genetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Atossa Genetics' future performance. For an informed investment choice regarding Atossa Stock, refer to the following important reports:

How To Invest In Atossa

Details

Is Atossa Stock a good investment?

Details

What is Atossa Genetics' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Atossa Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Atossa Stock please use our How to Invest in Atossa Genetics guide.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Atossa Stock analysis

When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.

	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals

Is Atossa Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.24)

Return On Assets

(0.18)

Return On Equity

(0.29)

The market value of Atossa Genetics is measured differently than its book value, which is the value of Atossa that is recorded on the company's balance sheet. Investors also form their own opinion of Atossa Genetics' value that differs from its market value or its book value, called intrinsic value, which is Atossa Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atossa Genetics' market value can be influenced by many factors that don't directly affect Atossa Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Atossa Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atossa Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atossa Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Atossa Net Debt vs Capital Surpluse Analysis

Net Debt vs Capital Surpluse

Net Debt vs Capital Surpluse Correlation Analysis

Correlation Coefficient

Net Debt

Capital Surpluse

Atossa Genetics fundamental ratios Correlations

Atossa Genetics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Atossa Genetics fundamental ratios Accounts

Pair Trading with Atossa Genetics

Moving together with Atossa Stock

Moving against Atossa Stock

Complementary Tools for Atossa Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Cash	+ 1.0	Total Stockholder Equity

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 1.0	Total Stockholder Equity
Net Debt	- 1.0	Total Assets
Other Stockholder Equity	- 0.97	Retained Earnings